181 related articles for article (PubMed ID: 35288309)
1. Timely treatment and higher compliance to traditional Chinese medicine: New influencing factors for reducing severe COVID-19 based on retrospective cohorts in 2020 and 2021.
Zhang Y; Liu Y; Li M; Feng S; Li X; Gao Z; Yang Y; Tong X
Pharmacol Res; 2022 Apr; 178():106174. PubMed ID: 35288309
[TBL] [Abstract][Full Text] [Related]
2. Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study.
Tian J; Yan S; Wang H; Zhang Y; Zheng Y; Wu H; Li X; Gao Z; Ai Y; Gou X; Zhang L; He L; Lian F; Liu B; Tong X
Pharmacol Res; 2020 Nov; 161():105127. PubMed ID: 32791263
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trial.
Liu Y; Chen X; Wang H; Yao C; Gou X; Gao Z; Sun L; Liu D; Tang C; Wei Y; Ding Q; Yang H; Lin J; Chen K; Chen J; Zhao L; Li M; Han L; Wang J; Ren J; Zhang Y
Front Pharmacol; 2022; 13():936925. PubMed ID: 36052134
[No Abstract] [Full Text] [Related]
4. Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China.
Wang Y; Lu C; Li H; Qi W; Ruan L; Bian Y; Shi H; Song H; Tu S; Zhang Y; Bai T; Cao R; Hong K; Li H; Liu L; Lu S; Rong N; Liu Y; Fang J; Shi J; Yang W; Zhao B; Yang Y; Zhao Y; Li S; Fan T; Rong P; Huang L
J Ethnopharmacol; 2021 Sep; 277():113888. PubMed ID: 33529638
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases.
Shu Z; Zhou Y; Chang K; Liu J; Min X; Zhang Q; Sun J; Xiong Y; Zou Q; Zheng Q; Ji J; Poon J; Liu B; Zhou X; Li X
Front Med; 2020 Dec; 14(6):760-775. PubMed ID: 32926319
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
[TBL] [Abstract][Full Text] [Related]
7. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
9. Traditional Chinese Medicine JingYinGuBiao Formula Therapy Improves the Negative Conversion Rate of SARS-CoV2 in Patients with Mild COVID-19.
Chen B; Geng P; Shen J; Liangpunsakul S; Lyu H; Zhang J; Yang Y; Zhang L; Xu Y; Dong C; Wang Y; Xue Y; Zhang W; Liu H; Li M; Gao Y
Int J Biol Sci; 2022; 18(15):5641-5652. PubMed ID: 36263182
[No Abstract] [Full Text] [Related]
10. The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial.
Li J; Zhang C; Wu Z; Wang G; Zhao H
Trials; 2020 Jun; 21(1):488. PubMed ID: 32503657
[TBL] [Abstract][Full Text] [Related]
11. Traditional Chinese Medicine Formulation Therapy in the Treatment of Coronavirus Disease 2019 (COVID-19).
Shi J; Lu Y; Zhang Y; Xia L; Ye C; Lü Y; Chen S; Xu Q; Tang B; Yin K; Zhang J; Chen X; Yang Z
Am J Chin Med; 2020; 48(7):1523-1538. PubMed ID: 33148005
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Adjuvant Efficacy of Natural Herbal Medicine on COVID-19: A Retrospective Matched Case-Control Study.
Zhang HT; Huang MX; Liu X; Zheng XC; Li XH; Chen GQ; Xia JY; Hong ZS
Am J Chin Med; 2020; 48(4):779-792. PubMed ID: 32420751
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.
Huang Q; Deng X; Li Y; Sun X; Chen Q; Xie M; Liu S; Qu H; Liu S; Wang L; He G; Gong Z
Int J Clin Pharm; 2020 Jun; 42(3):837-845. PubMed ID: 32410206
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of coronavirus disease 2019 in Gansu province, China.
Yue H; Bai X; Wang J; Yu Q; Liu W; Pu J; Wang X; Hu J; Xu D; Li X; Kang N; Li L; Lu W; Feng T; Ding L; Li X; Qi X;
Ann Palliat Med; 2020 Jul; 9(4):1404-1412. PubMed ID: 32692208
[TBL] [Abstract][Full Text] [Related]
15. Add-On Chinese Medicine for Coronavirus Disease 2019 (ACCORD): A Retrospective Cohort Study of Hospital Registries.
Shu Z; Chang K; Zhou Y; Peng C; Li X; Cai W; Wei L; Zheng Q; Tian H; Xia J; Yang K; Wang N; Liu J; Min X; Yan D; Sun J; Wu H; Li X; Zheng Y; Yu Z; Lu X; Yang Y; Jia T; Ji J; Zou Q; Wang Y; Xiao M; Zhang Q; Xiong Y; Sun F; Zhu Q; Jiang X; Wang G; Tang SC; Zhang J; Li X; Zhang N; Zhang B; Tong X; Liu B; Zhou X; Chan KW; Li X
Am J Chin Med; 2021; 49(3):543-575. PubMed ID: 33683189
[TBL] [Abstract][Full Text] [Related]
16. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study.
Zhang J; Litvinova M; Wang W; Wang Y; Deng X; Chen X; Li M; Zheng W; Yi L; Chen X; Wu Q; Liang Y; Wang X; Yang J; Sun K; Longini IM; Halloran ME; Wu P; Cowling BJ; Merler S; Viboud C; Vespignani A; Ajelli M; Yu H
Lancet Infect Dis; 2020 Jul; 20(7):793-802. PubMed ID: 32247326
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of clinical characteristics and prognosis of 4 264 patients with asymptomatic and mild novel coronavirus infections in Shanghai].
Xu X; Sun D; Cao M; Zhang W; Pu Y; Chen C; Sun Y; Zhou S; Fang B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 May; 34(5):449-453. PubMed ID: 35728842
[TBL] [Abstract][Full Text] [Related]
18. Attitudes of Chinese immigrants in Canada towards the use of Traditional Chinese Medicine for prevention and management of COVID-19: a cross-sectional survey during the early stages of the pandemic.
Kong Y; Shaver LG; Shi F; Yang L; Zhang W; Wei X; Zhu Y; Wang Y; Wang PP
BMJ Open; 2021 Sep; 11(9):e051499. PubMed ID: 34521675
[TBL] [Abstract][Full Text] [Related]
19. Acceptance and attitude towards the traditional chinese medicine among asymptomatic COVID-19 patients in Shanghai Fangcang hospital.
Pan B; Yin HW; Yu Y; Xiang X; Yu C; Yan XJ; Zhai XF; Bai Y; Hong J
BMC Complement Med Ther; 2023 Mar; 23(1):97. PubMed ID: 36997922
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019.
Lai J; Ma S; Wang Y; Cai Z; Hu J; Wei N; Wu J; Du H; Chen T; Li R; Tan H; Kang L; Yao L; Huang M; Wang H; Wang G; Liu Z; Hu S
JAMA Netw Open; 2020 Mar; 3(3):e203976. PubMed ID: 32202646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
